Jeff Olson, CEO of Nerium International, diverted more than $16 million to offshore accounts while a major shareholder went unpaid, according to a lawsuit filed by Nerium Skincare in August 2015. The suit alleges Olson's actions directly undercut profits owed to Nerium Skincare, which holds a 30% stake in his company.

Olson founded Nerium International and retains control as its chief executive. Nerium Skincare, by virtue of its significant ownership, expected proportional returns from the company's operations. For years, however, Olson allegedly funneled millions in company funds to personal accounts maintained outside the United States, effectively reducing the pool of distributable profits.

Trouble became apparent in July 2015 when Nerium Skincare requested access to Nerium International's financial records. The company's management denied this request repeatedly. Texas law grants shareholders the right to inspect corporate books, making the refusal a direct violation of standard corporate governance and suggesting a deliberate attempt to hide financial activities.

By February 2016, Nerium Skincare had accumulated evidence through legal subpoenas. These documents reportedly revealed what the plaintiff described as "concrete evidence of numerous inappropriate transactions—totaling millions of dollars—that were directed or overseen by Jeff Olson." The lawsuit explicitly stated Olson enriched himself at the company's expense, leaving no ambiguity about the alleged misconduct.

The full scope of the financial irregularities emerged when Nerium International eventually conceded that it had been compensating equity holders incorrectly for a significant period. This admission confirmed systemic issues in its payment structures. However, Olson's company declined to specify the exact amount it owed Nerium Skincare, maintaining a lack of transparency despite the confession.

Olson appears to be engaging in tactics designed to financially pressure his co-owner. Nerium International has withheld equity distributions from Nerium Skincare since February 2015. Bonus distributions have never been paid. The company has also reduced its purchases of NeriumAD, the flagship product, shifting its commercial focus to a different product line known as Optimera.

This strategy suggests an attempt to deplete Nerium Skincare's revenue streams, hoping to force a withdrawal from the lawsuit. The financial maneuvers directly impact Nerium Skincare's ability to operate and fund its legal challenge.

The distinguishing factor in this case lies in the source of the accusation. Unlike many claims against multi-level marketing firms, this lawsuit originates not from disgruntled distributors or customers, but from a substantial shareholder. Nerium Skincare is an insider, contractually entitled to payments under a Perpetual Distribution and Licensing Agreement, not an external party making general allegations.

Offshore accounts are frequently scrutinized in corporate disputes because they can be used to obscure asset ownership and evade financial oversight. The accusation of diverting funds to such accounts directly supports Nerium Skincare's claim that Olson is involved in "illegal financial schemes" rather than standard business operations.

Nerium Skincare's legal team is seeking a court order to compel Nerium International to open its financial records. This access is necessary to calculate the precise amount Olson allegedly misappropriated and the full sum owed to Nerium Skincare under their agreement.